From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making
AboutOpen · 19.12.2025 · 12 (1) · 43-46
DOI: 10.33393/ao.2025.3645 ↗Kurz gefasst
Fachartikel in der Zeitschrift AboutOpen, online erschienen am 19.12.2025. Verfasst von Maurizio Polignano und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The European Medicines Agency (EMA) has updated its Reflection Paper on the use of Real-WorldData (RWD) in Observational Studies (OS), emphasizing the regulatory importance of Real-World Evidence (RWE).
Objectives
Summarize the main methodological recommendations of the EMA’s 2025 guidance, highlightchallenges and opportunities for the use of RWD in regulatory contexts, and discuss implications for clinicalresearchers, with particular attention to the role of pharmacists.
Discussion
The new guidance distinguishes descriptive from causal OS and endorses Target Trial Emulation (TTE)to improve causal inference in observational research. It stresses transparency, reproducibility, and rigorous datagovernance, while calling for robust strategies to manage bias and confounding. Pharmacists are recognized askey contributors to drug utilization research and post-marketing surveillance, ensuring data quality and interoperability and supporting the integration of RWE into regulatory decision-making.
Conclusions
EMA’s roadmap affirms the value of RWE in strengthening regulatory science. Its implementationwill require cultural change, technical expertise, and resource allocation, offering both challenges and opportunitiesfor healthcare researchers, particularly pharmacists, to transform RWD into trusted evidence.
Zitieren
APA
Polignano, M., Lasala, R., Giannini, R., Ucciero, A., Romagnoli, A., Isgrò, V., Santoleri, F., & Costantini, A. (2025). From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making. AboutOpen, 12(1), 43-46. https://doi.org/10.33393/ao.2025.3645
Vancouver
Polignano M, Lasala R, Giannini R, Ucciero A, Romagnoli A, Isgrò V, et al. From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making. AboutOpen. 2025;12(1):43-46. doi:10.33393/ao.2025.3645
BibTeX
@article{Polignano2025,
author = {Polignano, Maurizio and Lasala, Ruggero and Giannini, Romina and Ucciero, Andrealuna and Romagnoli, Alessia and Isgrò, Valentina and Santoleri, Fiorenzo and Costantini, Alberto},
title = {From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making},
journal = {AboutOpen},
year = {2025},
volume = {12},
number = {1},
pages = {43--46},
doi = {10.33393/ao.2025.3645}
}
EUVIMED